NCT05418894 Mapping and Modulating the Spatiotemporal Dynamics of Socio-Affective Processing Status RECRUITING Phase NA
NCT05414422 A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRD Status COMPLETED Phase PHASE2
NCT05355142 An Intervention Study of Anhedonia and Pain Empathy in Depression Status UNKNOWN Phase NA
NCT05220410 The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation Status COMPLETED Phase PHASE2
NCT05144789 Personalized Therapeutic Neuromodulation for Anhedonic Depression Status COMPLETED Phase NA
NCT05139862 Neurocardiac Predictors of Treatment Response to RTMS in Depression Status NOT_YET_RECRUITING Phase NA
NCT05113771 A Biomarker-Guided, Randomized, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With TRD Status COMPLETED Phase PHASE2
NCT05066672 Phase 2 Study of NV-5138 in Adults With Treatment Resistant Depression Status COMPLETED Phase PHASE2
NCT04971291 An Evaluation of AXS-05 for the Treatment of TRD in Treatment-Adherent Patients Status UNKNOWN Phase PHASE2
NCT04957368 Sustained Mood Improvement With Laughing Gas Exposure: A Randomized Controlled Pilot Trial Status COMPLETED Phase PHASE4
NCT04956081 Virtual Neuro-Navigation System for Personalized Community Based TMS Status COMPLETED Phase NA
NCT04936126 Comparison of Antidepressant Augmentation With Amantadine vs Pramipexole vs Quetiapine in Treatment Resistant Depression Status UNKNOWN Phase PHASE4
NCT04935489 Accelerated Intermittent Theta Burst Stimulation for Depressed Patients During the Covid-19 Pandemic Status COMPLETED Phase NA